Ask The Expert: SABCS Highlights

SABCS 2022: New breast cancer treatmentsПодробнее

SABCS 2023 Breast Cancer Highlights – NATALEE, MONARCH-3, INAVO120, TROPION-Breast01Подробнее

Breast Cancer: Whether to pause Hormone Therapy for PregnancyПодробнее

Early Breast Cancer Treatment: Tamoxifen dosage optionsПодробнее

CDK4/6 inhibitors: Can they be used for TNBC or HER2+ breast cancer?Подробнее

Can vaginal estrogen be an issue with endocrine therapy?Подробнее

Breast Cancer Recurrence Risk based on ctDNAПодробнее

Genetic markers and risk of second breast cancer basedПодробнее

CDK4/6 for HR+ early breast cancer: monarchE resultsПодробнее

What is HER2 low in breast cancer?Подробнее

Highlights from SABCS 2023Подробнее

SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 UpdateПодробнее

Ask the expert: Updates from the 2023 San Antonio Breast Cancer Symposium (SABCS)Подробнее

SABCS 2022 highlightsПодробнее

SABCS 2023 HER2+ Breast Cancer Highlights – APHINITY Sub-analysis, KATHERINE update, HER2CLIMB-02Подробнее

Key highlights from SABCS 2022Подробнее

SABCS 2022: clinical trial highlightsПодробнее

SABCS 2022 highlightsПодробнее

Dr. Bora Lim | Challenging Types of Breast Cancer | SABCS 2022 | Education SessionПодробнее